Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × niraparib × Gynecologic × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 65 Fallopian Tube Neoplasms 17 Breast Neoplasms 7 Endometrial Neoplasms 6 Carcinoma, Ovarian Epithelial 5 Pancreatic Neoplasms 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Uterine Neoplasms 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytopenia 1 Sarcoma 1 Recurrent/ Advanced Stage Endometrial Cancer Patients 1 Recurrence 1 Prostatic Diseases 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Platinum-resistant Ovarian Cancer 1 Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma 1 Ovarian Diseases 1 Ovarian Carcinosarcoma 1 Neutropenia 1 Nausea 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Saline Solution 3 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 niraparib 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Hyperthermic Intraperitoneal Chemotherapy 1 Carboplatin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07059676 2025-07-11

LIBINI-1

Clinica Universidad de Navarra, Universidad de Navarra

Not yet recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡